Health+Benefits

On the Mic with David Axelrod

The Council’s Joel Wood follows up with political analyst David Axelrod for an enlightening, informative and human interview.
By Joel Wood Posted on December 14, 2020

On the Mic with David Axelrod

Hosted by Joel Wood, SVP, Government Affairs, The Council With Guest David Axelrod, National Political Analyst
On the Mic with David Axelrod
0:00
Listen With soundcloud

In a follow up to their conversation during this year’s (virtual) Insurance Leadership Forum, Joel Wood, The Council’s SVP of Government Affairs, and national political analyst David Axelrod, discuss the incoming administration, what may come of the ACA, prospects of a public option, Medicare, prescription drug costs and more.

“It’ll be interesting to see how people feel about the pharmaceutical industry in the midst of these vaccines…Because the reality is that these are lifesaving drugs. The question is, what is reasonable? And because they are lifesaving drugs, to deprive people of them because they are so expensive, is essentially to deprive them of the chance to live. And that’s what makes this different.”

Joel Wood Senior Vice President, Government Affairs, The Council Read More

More Podcasts

Private Equity Infusion
Brokerage Ops Private Equity Infusion
Two experts break down the runway left in retail brokerage M&A, alternative acqu...
Brokerage Ops From Broker to Techie
Q&A with Andy Mathisen, Co-Founder and CMO, GloveBox
Global Trend Watcher Vikram Mansharamani
Industry Global Trend Watcher Vikram Mansharamani
Talks five-year forecast on the global economy, U.S. politics, technology, cyber...
Former FDA Commissioner Scott Gottlieb
Health+Benefits Former FDA Commissioner Scott Gottlieb
On the vaccine supply and distribution, the future of the ACA, and drug pricing ...
Budding Broker
Brokerage Ops Budding Broker
Q&A with Drew Taylor, Broker, Founder Shield
Young Talent Speaks
Industry Young Talent Speaks
A new podcast series